Takehiro Hagiwara
About
In The Last Decade
Takehiro Hagiwara
9 papers receiving 557 citations
Peers
Comparison fields: 5 of 74
- Molecular Biology 423
- Oncology 292
- Pulmonary and Respiratory Medicine 88
- Pharmacology 85
- Cardiology and Cardiovascular Medicine 63
Countries citing papers authored by Takehiro Hagiwara
This map shows the geographic impact of Takehiro Hagiwara's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Takehiro Hagiwara with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Takehiro Hagiwara more than expected).
Fields of papers citing papers by Takehiro Hagiwara
This network shows the impact of papers produced by Takehiro Hagiwara. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Takehiro Hagiwara. The network helps show where Takehiro Hagiwara may publish in the future.
Co-authorship network of co-authors of Takehiro Hagiwara
This figure shows the co-authorship network connecting the top 25 collaborators of Takehiro Hagiwara. A scholar is included among the top collaborators of Takehiro Hagiwara based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Takehiro Hagiwara. Takehiro Hagiwara is excluded from the visualization to improve readability, since they are connected to all nodes in the network.
All Works
| # | Work | Indexed citations |
|---|---|---|
| 1 | 7 | |
| 2 | 22 | |
| 3 | 36 | |
| 4 | 27 | |
| 5 | 3 | |
| 6 | 91 | |
| 7 | Involvement of beta-glucuronidase in intestinal microflora in the intestinal toxicity of the antitumor camptothecin derivative irinotecan hydrochloride (CPT-11) in rats. | 295 |
| 8 | 1 | |
| 9 | 85 |
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.